Price alert —
Sign in to get a one-time email the moment KVUE crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · KVUE
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.9B | $0.5B | $0.8B | $0.3B | 12.1% | 21.4% |
| 2025-12-31 | $3.8B | $0.3B | $0.6B | $0.7B | 8.7% | 16.7% |
| 2025-09-30 | $3.8B | $0.4B | $0.7B | $0.2B | 10.6% | 18.9% |
| 2025-06-30 | $3.8B | $0.4B | $0.8B | $0.5B | 10.9% | 19.6% |
| 2025-03-31 | $3.7B | $0.3B | $0.6B | $0.2B | 8.6% | 16.5% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare KVUE vs peers
Line KVUE up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with KVUE
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 12 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-07 | 0.32 | 0.26 | +23.0% | -0.7% |
| 2026-02-17 | 0.27 | 0.22 | +21.2% | +2.5% |
| 2025-11-03 | 0.28 | 0.26 | +5.7% | -1.1% |
| 2025-08-07 | 0.29 | 0.28 | +2.2% | -1.9% |
| 2025-05-08 | 0.24 | 0.23 | +5.4% | +1.6% |
| 2025-02-06 | 0.26 | 0.26 | +1.5% | +1.9% |
| 2024-11-07 | 0.28 | 0.27 | +3.0% | +3.1% |
| 2024-08-06 | 0.32 | 0.28 | +15.7% | -1.1% |
| 2024-05-07 | 0.28 | 0.25 | +10.3% | +1.8% |
| 2024-02-08 | 0.31 | 0.28 | +9.8% | +0.0% |
| 2023-10-26 | 0.31 | 0.31 | -1.4% | -2.6% |
| 2023-07-20 | 0.32 | 0.30 | +6.9% | -2.0% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Consumer Defensive
Context check: the same key numbers for the closest Consumer Defensive names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| KVUE ★ | $36B | 22.5 | 15.2 | 2.4 | 12.8 | 3.4 | 58.6% | 4.5% | 46.9% | 5.13% |
| WMT | $888B | 39.3 | 34.0 | 1.2 | 21.5 | 9.4 | 25.0% | 7.3% | 19.4% | 0.77% |
| PG | $344B | 21.6 | 20.9 | — | 14.9 | 6.4 | 51.0% | 7.4% | 5.8% | 3.70% |
| KO | $352B | 25.8 | 23.5 | — | 23.1 | 10.5 | 61.7% | 12.1% | 18.2% | 0.89% |
| PEP | $184B | 17.7 | 15.0 | 1.9 | 12.1 | 8.6 | 54.2% | 6.4% | 137.0% | 4.25% |
| COST | $411B | 46.7 | 40.9 | 1.4 | 30.0 | 24.9 | 12.9% | 21.5% | 45.5% | 1.69% |
| PM | — | 27.0 | 21.0 | — | 18.8 | — | 67.3% | 9.1% | -9.3% | — |
| MO | $123B | 15.4 | 12.5 | — | 9.2 | -38.4 | 87.4% | 5.3% | 106.3% | 6.94% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 44.33%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 145,297,292 | 7.57% |
| FMR, LLC | 135,093,094 | 7.04% |
| Vanguard Capital Management LLC | 124,424,037 | 6.48% |
| State Street Corporation | 119,571,246 | 6.23% |
| Vanguard Portfolio Management LLC | 92,464,388 | 4.82% |
| Pentwater Capital Management Lp | 52,000,000 | 2.71% |
| Geode Capital Management, LLC | 51,270,216 | 2.67% |
| Massachusetts Financial Services Co. | 49,743,984 | 2.59% |
| Independent Franchise Partners, LLP | 49,208,848 | 2.56% |
| Millennium Management Llc | 31,801,263 | 1.66% |
Insider activity · 90d
13 buys / 2 sells · ratio 6.5 · Finnhub
- ALLISON RICHARD E JR BUY 49,798
- Smith Jeffrey C BUY 27,023
- Howlett Heather SELL 29,288 @ $18.11
- Mann Erica L BUY 19,986 @ $17.46
- Godbole Seemantini BUY 36,627 @ $17.46
- Hofstetter Sarah BUY 24,102 @ $17.46
- Sneed Michael E BUY 36,627 @ $17.46
- PAWLUS KATHLEEN M BUY 25,038 @ $17.46
- ALLISON RICHARD E JR BUY 47,943 @ $17.46
- Healey Melanie BUY 36,627 @ $17.46
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-01 | OWNERSHIP DOCUMENT | view · |
| 4 | 2026-07-01 | FORM 4 | view · |
| 4 | 2026-06-12 | FORM 4 | view · |
| 4 | 2026-05-26 | OWNERSHIP DOCUMENT | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-26 | FORM 4 | view · |
| 8-K | 2026-05-22 | 8-K | view · |
| 4 | 2026-05-12 | FORM 4 | view · |
| 10-Q | 2026-05-07 | 10-Q | view · |
| 8-K | 2026-05-07 | 8-K | view · |
| 8-K | 2026-04-15 | CURRENT REPORT | view · |
| DEF 14A | 2026-04-08 | DEF 14A | view · |
| 4 | 2026-04-01 | OWNERSHIP DOCUMENT | view · |
| 4 | 2026-03-31 | FORM 4 | view · |
| 4 | 2026-03-12 | FORM 4 | view · |
| 4 | 2026-03-12 | FORM 4 | view · |
| 4 | 2026-03-12 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 10-K | 2026-02-20 | 10-K | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 4 | 2026-02-18 | FORM 4 | view · |
| 8-K | 2026-02-17 | 8-K | view · |
| 8-K | 2026-02-12 | CURRENT REPORT | view · |
| 4 | 2026-02-10 | FORM 4 | view · |
| 8-K | 2026-01-29 | 8-K | view · |
| 8-K | 2026-01-16 | 8-K | view · |
| 4 | 2026-01-06 | FORM 4 | view · |
| 4 | 2026-01-06 | FORM 4 | view · |
| 4 | 2025-12-17 | FORM 4 | view · |
| 4 | 2025-12-17 | FORM 4 | view · |
| 4 | 2025-12-17 | FORM 4 | view · |
| 4 | 2025-12-17 | FORM 4 | view · |
| 4 | 2025-12-17 | FORM 4 | view · |
About KVUE
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was inco…
Options picks · KVUE
ITM + OTM ideas from the latest scanLoading…
Congress trades · KVUE
STOCK Act disclosuresLoading…
SEC filings & insiders · KVUE
EDGAR · liveLoading…
Holders · KVUE
Institutions & insider activityLoading…